8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Feb 20, 2026·SEC
Material company update
Jan 29, 2026·SEC
Eastman Chemical Company(EMN)Earnings, Financials & Key Ratios
EMN•NYSE
17.7× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustrySpecialty polymers and engineered plastics
AboutEastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon and rosin resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral (PVB) sheets, and window and protective films, and aftermarket applied film products for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non- phthalate plasticizers to the industrial chemicals and processing, building and construction, health and wellness, and agrochemicals. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.Show more
- Revenue$8.75B-6.7%
- EBITDA$1.44B-23.4%
- Net Income$474M-47.6%
- EPS (Diluted)4.10-46.5%
- Gross Margin21.07%-13.7%
- EBITDA Margin16.5%-17.9%
- Operating Margin10.64%-27.5%
- Net Margin5.42%-43.9%
- ROE7.97%-49.9%
EMN Key Insights
Eastman Chemical Company (EMN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓16 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 4.5%
- ✓Trading at only 1.4x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when EMN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
EMN Price & Volume
Eastman Chemical Company (EMN) stock price & volume — 10-year historical chart
Loading chart...
EMN Growth Metrics
Eastman Chemical Company (EMN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-0.88%
5 Years0.67%
3 Years-5.99%
TTM-7.72%
Profit CAGR
10 Years-5.65%
5 Years-0.17%
3 Years-15.76%
TTM-56.72%
EPS CAGR
10 Years-3.17%
5 Years3.22%
3 Years-13.57%
TTM-55.98%
Return on Capital
10 Years9.83%
5 Years9.63%
3 Years9.36%
Last Year7.53%
EMN Recent Earnings
Eastman Chemical Company (EMN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.09+1.9%
$1.07
Rev
$2.2B+0.2%
$2.2B
Q1 2026
Jan 29, 2026Metric
Actual
Est
EPS
$0.75-1.3%
$0.76
Rev
$2.0B-2.3%
$2.0B
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$1.14-1.7%
$1.16
Rev
$2.2B-2.5%
$2.3B
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$1.60-7.0%
$1.72
Rev
$2.3B-2.8%
$2.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.09vs $1.07+1.9% | $2.2Bvs $2.2B+0.2% |
| Q1 2026 | Jan 29, 2026 | $0.75vs $0.76-1.3% | $2.0Bvs $2.0B-2.3% |
| Q4 2025 | Nov 3, 2025 | $1.14vs $1.16-1.7% | $2.2Bvs $2.3B-2.5% |
| Q3 2025 | Jul 31, 2025 | $1.60vs $1.72-7.0% | $2.3Bvs $2.4B-2.8% |
Based on last 12 quarters of dataView full earnings history →
EMN Peer Comparison
Eastman Chemical Company (EMN) competitors in Specialty polymers and engineered plastics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 LYB | 19.35B | 60.07 | -25.56 | -25.18% | -3.44% | -7.2% | 1.56 | |
 CE | 5.73B | 51.16 | -4.81 | -7.16% | -10.79% | -21.51% | 2.89 | |
 HUN | 2.1B | 12.07 | -7.59 | -5.85% | -5.69% | -8.14% | 0.92 | |
 AVNT | 3.45B | 37.66 | 42.31 | 0.61% | 4.81% | 6.6% | 0.81 | |
 ASH | 3.11B | 67.92 | -3.70 | -13.68% | -39.03% | -37.54% | 0.83 | |
 FMC | 1.44B | 11.55 | -0.65 | -18.34% | -72.93% | -82.27% | 2.00 | |
 DOW | 22.83B | 31.73 | -8.60 | -6.97% | -7.02% | -15.35% | 1.12 | |
 DD | 19.55B | 47.69 | -25.64 | -44.7% | -0.3% | -0.15% | 0.23 |
Compare EMN vs Peers
Eastman Chemical Company (EMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
EMN Income Statement
Eastman Chemical Company (EMN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 9.51B | 10.12B | 9.25B | 8.46B | 10.48B | 10.54B | 9.2B | 9.38B | 8.75B | 8.64B |
Revenue Growth % | 6.36% | 6.39% | -8.64% | -8.47% | 23.85% | 0.5% | -12.69% | 2% | -6.71% | -7.72% |
Cost of Goods Sold | 7.03B | 7.69B | 7B | 6.46B | 7.96B | 8.48B | 7.14B | 7.09B | 6.91B | 6.93B |
COGS % of Revenue | 73.9% | 76% | 75.69% | 76.31% | 75.98% | 80.48% | 77.58% | 75.59% | 78.93% | - |
Gross Profit | 2.48B▲ 0% | 2.43B▼ 2.2% | 2.25B▼ 7.5% | 2B▼ 10.8% | 2.52B▲ 25.6% | 2.06B▼ 18.3% | 2.06B▲ 0.3% | 2.29B▲ 11.1% | 1.84B▼ 19.5% | 1.71B▲ 0% |
Gross Margin % | 26.1% | 24% | 24.31% | 23.69% | 24.02% | 19.52% | 22.42% | 24.41% | 21.07% | 19.77% |
Gross Profit Growth % | 1.14% | -2.17% | -7.45% | -10.81% | 25.59% | -18.35% | 0.29% | 11.06% | -19.48% | - |
Operating Expenses | 956M | 956M | 925M | 880M | 1.05B | 972M | 966M | 914M | 913M | 900M |
OpEx % of Revenue | 10.05% | 9.44% | 10% | 10.4% | 10.01% | 9.23% | 10.5% | 9.74% | 10.43% | - |
Selling, General & Admin | 729M | 721M | 691M | 654M | 795M | 708M | 727M | 664M | 658M | 652M |
SG&A % of Revenue | 7.66% | 7.12% | 7.47% | 7.73% | 7.58% | 6.72% | 7.9% | 7.08% | 7.52% | - |
Research & Development | 214M | 235M | 234M | 226M | 254M | 264M | 239M | 250M | 255M | 248M |
R&D % of Revenue | 2.25% | 2.32% | 2.53% | 2.67% | 2.42% | 2.51% | 2.6% | 2.66% | 2.91% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 1.53B▲ 0% | 1.47B▼ 3.5% | 1.32B▼ 10.2% | 1.13B▼ 15.0% | 1.47B▲ 30.6% | 1.08B▼ 26.2% | 1.1B▲ 1.1% | 1.38B▲ 25.5% | 931M▼ 32.3% | 808M▲ 0% |
Operating Margin % | 16.05% | 14.55% | 14.31% | 13.29% | 14.01% | 10.29% | 11.92% | 14.67% | 10.64% | 9.35% |
Operating Income Growth % | -0.97% | -3.54% | -10.18% | -14.97% | 30.58% | -26.21% | 1.11% | 25.55% | -32.34% | - |
EBITDA | 2.11B | 2.07B | 1.93B | 1.7B | 2.01B | 1.56B | 1.59B | 1.89B | 1.44B | 1.2B |
EBITDA Margin % | 22.19% | 20.49% | 20.9% | 20.07% | 19.15% | 14.82% | 17.33% | 20.09% | 16.5% | 13.83% |
EBITDA Growth % | -0.52% | -1.75% | -6.8% | -12.11% | 18.13% | -22.22% | 2.11% | 18.26% | -23.4% | -37.89% |
D&A (Non-Cash Add-back) | 584M | 601M | 610M | 574M | 538M | 477M | 498M | 509M | 513M | 387M |
EBIT | 1.53B | 1.54B | 1.12B | 735M | 1.27B | 1.16B | 1.31B | 1.29B | 776M | 479M |
Net Interest Income | -241M | -235M | -218M | -201M | -189M | -182M | -215M | -200M | -208M | -159M |
Interest Income | 3M | 3M | 3M | 4M | 3M | 6M | 10M | 16M | 0 | 5M |
Interest Expense | 244M | 238M | 221M | 205M | 192M | 188M | 225M | 216M | 208M | 216M |
Other Income/Expense | -238M | -163M | -421M | -595M | -387M | -107M | -9M | -298M | -363M | -357M |
Pretax Income | 1.3B▲ 0% | 1.31B▲ 0.6% | 902M▼ 31.1% | 530M▼ 41.2% | 1.08B▲ 104.2% | 977M▼ 9.7% | 1.09B▲ 11.3% | 1.08B▼ 0.8% | 568M▼ 47.3% | 451M▲ 0% |
Pretax Margin % | 13.69% | 12.94% | 9.75% | 6.26% | 10.32% | 9.27% | 11.82% | 11.49% | 6.49% | 5.22% |
Income Tax | -177M | 226M | 140M | 41M | 215M | 181M | 191M | 170M | 93M | 52M |
Effective Tax Rate % | -13.59% | 17.25% | 15.52% | 7.74% | 19.87% | 18.53% | 17.57% | 15.77% | 16.37% | 11.53% |
Net Income | 1.47B▲ 0% | 1.08B▼ 26.7% | 759M▼ 29.7% | 478M▼ 37.0% | 857M▲ 79.3% | 793M▼ 7.5% | 894M▲ 12.7% | 905M▲ 1.2% | 474M▼ 47.6% | 399M▲ 0% |
Net Margin % | 15.49% | 10.67% | 8.21% | 5.65% | 8.18% | 7.53% | 9.72% | 9.65% | 5.42% | 4.62% |
Net Income Growth % | 70.21% | -26.73% | -29.72% | -37.02% | 79.29% | -7.47% | 12.74% | 1.23% | -47.62% | -56.72% |
Net Income (Continuing) | 1.39B | 1.08B | 762M | 489M | 867M | 796M | 896M | 908M | 475M | 399M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 77M | 75M | 74M | 85M | 84M | 83M | 72M | 73M | 76M | 77M |
EPS (Diluted) | 10.09▲ 0% | 7.56▼ 25.1% | 5.48▼ 27.5% | 3.50▼ 36.1% | 6.25▲ 78.6% | 6.35▲ 1.6% | 7.49▲ 18.0% | 7.67▲ 2.4% | 4.10▼ 46.5% | -▲ 0% |
EPS Growth % | 72.77% | -25.07% | -27.51% | -36.13% | 78.57% | 1.6% | 17.95% | 2.4% | -46.54% | -55.98% |
EPS (Basic) | 10.18 | 7.65 | 5.52 | 3.53 | 6.35 | 6.42 | 7.54 | 7.75 | 4.13 | - |
Diluted Shares Outstanding | 146.1M | 142.9M | 138.5M | 136.5M | 137.1M | 124.9M | 119.4M | 117.9M | 115.6M | 0 |
Basic Shares Outstanding | 144.8M | 141.2M | 137.4M | 135.5M | 134.9M | 123.5M | 118.6M | 116.7M | 114.7M | 0 |
Dividend Payout Ratio | 20.08% | 29.44% | 45.19% | 74.9% | 43.76% | 48.05% | 42.06% | 41.88% | 80.38% | - |
EMN Balance Sheet
Eastman Chemical Company (EMN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 3.14B | 3.37B | 3.32B | 3.54B | 4.65B | 3.78B | 3.48B | 4.1B | 3.65B | 4.06B |
Cash & Short-Term Investments | 191M | 226M | 204M | 564M | 459M | 493M | 548M | 837M | 566M | 665M |
Cash Only | 191M | 226M | 204M | 564M | 459M | 493M | 548M | 837M | 566M | 665M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 1.39B | 1.48B | 1.38B | 1.51B | 1.58B | 1.28B | 1.15B | 1.17B | 999M | 949M |
Days Sales Outstanding | 53.17 | 53.48 | 54.27 | 65.33 | 55.01 | 44.24 | 45.79 | 45.6 | 41.66 | 48.19 |
Inventory | 1.51B | 1.58B | 1.66B | 1.38B | 1.5B | 1.89B | 1.68B | 1.99B | 1.98B | 2.08B |
Days Inventory Outstanding | 78.34 | 75.11 | 86.67 | 77.93 | 68.92 | 81.53 | 86.08 | 102.32 | 104.62 | 107.25 |
Other Current Assets | 57M | 73M | 80M | 83M | 1.1B | 114M | 96M | 104M | 100M | 364M |
Total Non-Current Assets | 12.86B | 12.63B | 12.69B | 12.54B | 10.87B | 10.89B | 11.15B | 11.11B | 11.21B | 11.17B |
Property, Plant & Equipment | 5.61B | 5.6B | 5.57B | 5.55B | 5B | 5.16B | 5.55B | 5.62B | 5.92B | 0 |
Fixed Asset Turnover | 1.70x | 1.81x | 1.66x | 1.53x | 2.10x | 2.04x | 1.66x | 1.67x | 1.48x | 1.98x |
Goodwill | 4.53B | 4.47B | 4.43B | 4.46B | 3.64B | 3.66B | 3.65B | 3.63B | 3.67B | 3.66B |
Intangible Assets | 2.37B | 2.19B | 2.01B | 1.79B | 1.36B | 1.21B | 1.14B | 1.03B | 970M | 946M |
Long-Term Investments | -893M | -884M | 0 | 0 | 145M | 183M | 124M | 186M | 111M | 111M |
Other Non-Current Assets | 349M | 378M | 674M | 736M | 729M | 672M | 696M | 647M | 546M | 6.56B |
Total Assets | 16B▲ 0% | 15.99B▼ 0.0% | 16.01B▲ 0.1% | 16.08B▲ 0.5% | 15.52B▼ 3.5% | 14.67B▼ 5.5% | 14.63B▼ 0.2% | 15.21B▲ 4.0% | 14.86B▼ 2.3% | 15.22B▲ 0% |
Asset Turnover | 0.59x | 0.63x | 0.58x | 0.53x | 0.68x | 0.72x | 0.63x | 0.62x | 0.59x | 0.57x |
Asset Growth % | 3.51% | -0.03% | 0.08% | 0.47% | -3.51% | -5.49% | -0.23% | 3.96% | -2.33% | 0.65% |
Total Current Liabilities | 1.98B | 1.85B | 1.79B | 2.04B | 2.97B | 3.25B | 2.58B | 2.71B | 2.65B | 2.77B |
Accounts Payable | 842M | 914M | 890M | 799M | 1.23B | 1.32B | 1.17B | 1.31B | 1.21B | 0 |
Days Payables Outstanding | 43.71 | 43.37 | 46.41 | 45.15 | 56.27 | 56.78 | 59.84 | 67.37 | 63.99 | 66.53 |
Short-Term Debt | 393M | 243M | 171M | 349M | 797M | 1.13B | 593M | 499M | 642M | 0 |
Deferred Revenue (Current) | 399M | 94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 548M | 417M | 373M | 390M | 326M | 391M | 218M | 379M | 396M | 2.77B |
Current Ratio | 1.59x | 1.82x | 1.86x | 1.74x | 1.56x | 1.16x | 1.35x | 1.51x | 1.37x | 1.47x |
Quick Ratio | 0.82x | 0.96x | 0.93x | 1.06x | 1.06x | 0.58x | 0.70x | 0.78x | 0.63x | 0.71x |
Cash Conversion Cycle | 87.8 | 85.22 | 94.53 | 98.11 | 67.66 | 69 | 72.03 | 80.54 | 82.29 | 88.91 |
Total Non-Current Liabilities | 8.54B | 8.27B | 8.19B | 7.94B | 6.76B | 6.18B | 6.53B | 6.65B | 6.17B | 6.37B |
Long-Term Debt | 6.15B | 5.92B | 5.61B | 5.27B | 4.57B | 4.03B | 4.42B | 4.66B | 4.32B | 0 |
Capital Lease Obligations | 5M | 0 | 0 | 0 | 157M | 0 | 120M | 96M | 117M | 117M |
Deferred Tax Liabilities | 893M | 884M | 915M | 848M | 810M | 671M | 601M | 533M | 669M | 2.3B |
Other Non-Current Liabilities | 1.49B | 1.46B | 1.66B | 1.82B | 1.22B | 1.48B | 1.38B | 1.36B | 1.07B | 5.69B |
Total Liabilities | 10.52B | 10.12B | 9.98B | 9.97B | 9.73B | 9.43B | 9.1B | 9.36B | 8.82B | 9.14B |
Total Debt | 6.54B | 6.17B | 5.78B | 5.62B | 5.52B | 5.15B | 5.14B | 5.26B | 5.08B | 0 |
Net Debt | 6.35B | 5.94B | 5.58B | 5.05B | 5.06B | 4.66B | 4.59B | 4.42B | 4.51B | -665M |
Debt / Equity | 1.17x | 1.05x | 0.96x | 0.92x | 0.95x | 0.98x | 0.93x | 0.90x | 0.84x | 0.00x |
Debt / EBITDA | 3.10x | 2.97x | 2.99x | 3.31x | 2.75x | 3.30x | 3.22x | 2.79x | 3.52x | 0.00x |
Net Debt / EBITDA | 3.01x | 2.86x | 2.89x | 2.97x | 2.52x | 2.98x | 2.88x | 2.35x | 3.12x | -0.56x |
Interest Coverage | 6.26x | 6.48x | 5.05x | 3.59x | 6.64x | 6.16x | 5.82x | 5.99x | 3.73x | 2.22x |
Total Equity | 5.57B▲ 0% | 5.88B▲ 5.5% | 6.03B▲ 2.6% | 6.11B▲ 1.3% | 5.79B▼ 5.2% | 5.24B▼ 9.5% | 5.53B▲ 5.6% | 5.85B▲ 5.8% | 6.04B▲ 3.2% | 6.09B▲ 0% |
Equity Growth % | 20.56% | 5.51% | 2.62% | 1.26% | -5.24% | -9.54% | 5.62% | 5.82% | 3.16% | 11.19% |
Book Value per Share | 38.13 | 41.13 | 43.55 | 44.75 | 42.22 | 41.92 | 46.31 | 49.64 | 52.22 | - |
Total Shareholders' Equity | 5.49B | 5.8B | 5.96B | 6.02B | 5.7B | 5.15B | 5.46B | 5.78B | 5.96B | 6.01B |
Common Stock | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M |
Retained Earnings | 6.8B | 7.57B | 7.96B | 8.08B | 8.56B | 8.97B | 9.49B | 10.01B | 10.11B | 10.11B |
Treasury Stock | -3.17B | -3.58B | -3.9B | -3.96B | -4.86B | -5.93B | -6.08B | -6.38B | -6.49B | 0 |
Accumulated OCI | -209M | -245M | -214M | -273M | -182M | -205M | -319M | -314M | -160M | -141M |
Minority Interest | 77M | 75M | 74M | 85M | 84M | 83M | 72M | 73M | 76M | 77M |
EMN Cash Flow Statement
Eastman Chemical Company (EMN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.66B | 1.54B | 1.5B | 1.46B | 1.62B | 975M | 1.37B | 1.29B | 970M | 1B |
Operating CF Margin % | 17.42% | 15.24% | 16.26% | 17.19% | 15.44% | 9.25% | 14.94% | 13.72% | 11.08% | - |
Operating CF Growth % | 19.64% | -6.88% | -2.53% | -3.26% | 11.27% | -39.78% | 40.92% | -6.33% | -24.63% | -24.07% |
Net Income | 1.39B | 1.08B | 762M | 489M | 867M | 796M | 896M | 908M | 474M | 399M |
Depreciation & Amortization | 587M | 604M | 611M | 574M | 538M | 477M | 498M | 509M | 513M | 518M |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -49M |
Deferred Taxes | -394M | -51M | 23M | -111M | -38M | -136M | -102M | -52M | 141M | 139M |
Other Non-Cash Items | -67M | -21M | 134M | 338M | 279M | -175M | -209M | -49M | 28M | -294M |
Working Capital Changes | 143M | -73M | -26M | 165M | -27M | 13M | 291M | -29M | -186M | 287M |
Change in Receivables | -53M | 16M | 170M | -31M | -281M | 93M | 126M | 28M | 61M | -69M |
Change in Inventory | -71M | -224M | -80M | 291M | -389M | -430M | 201M | -344M | 24M | 25M |
Change in Payables | 123M | 90M | -27M | -100M | 554M | 60M | -190M | 188M | -76M | -4M |
Cash from Investing | -643M | -463M | -480M | -394M | -29M | 392M | -432M | -534M | -462M | -435M |
Capital Expenditures | -649M | -528M | -425M | -383M | -555M | -611M | -828M | -599M | -546M | -502M |
CapEx % of Revenue | 6.82% | 5.22% | 4.6% | 4.52% | 5.29% | 5.8% | 9% | 6.38% | 6.24% | 5.81% |
Acquisitions | -4M | -3M | -48M | -1M | 553M | 997M | 379M | 38M | 38M | 38M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 10M | 68M | -7M | -10M | -27M | 6M | 17M | 27M | 46M | 29M |
Cash from Financing | -1.01B | -1.04B | -1.04B | -704M | -1.69B | -1.32B | -888M | -454M | -797M | -332M |
Debt Issued (Net) | -369M | -316M | -370M | -307M | -350M | 76M | -338M | 198M | -304M | -285M |
Equity Issued (Net) | -350M | -400M | -325M | -60M | -1B | -1B | -150M | -300M | -100M | -100M |
Dividends Paid | -296M | -318M | -343M | -358M | -375M | -381M | -376M | -379M | -381M | -381M |
Share Repurchases | -350M | -400M | -325M | -60M | -1B | -1B | -150M | -300M | -100M | -100M |
Other Financing | 9M | -6M | -5M | 21M | 35M | -14M | -24M | 27M | -12M | 434M |
Net Change in Cash | 10M▲ 0% | 35M▲ 250.0% | -22M▼ 162.9% | 360M▲ 1736.4% | -105M▼ 129.2% | 34M▲ 132.4% | 55M▲ 61.8% | 289M▲ 425.5% | -837M▼ 389.6% | -319M▲ 0% |
Free Cash Flow | 1.01B▲ 0% | 1.01B▲ 0.7% | 1.07B▲ 5.7% | 1.06B▼ 1.3% | 1.04B▼ 1.7% | 364M▼ 65.0% | 546M▲ 50.0% | 688M▲ 26.0% | 424M▼ 38.4% | 498M▲ 0% |
FCF Margin % | 10.59% | 10.03% | 11.6% | 12.51% | 9.93% | 3.46% | 5.94% | 7.33% | 4.84% | 5.76% |
FCF Growth % | 32.81% | 0.69% | 5.71% | -1.3% | -1.7% | -65.03% | 50% | 26.01% | -38.37% | -13.39% |
FCF per Share | 6.90 | 7.10 | 7.75 | 7.76 | 7.59 | 2.91 | 4.57 | 5.84 | 3.67 | - |
FCF Conversion (FCF/Net Income) | 1.12x | 1.43x | 1.98x | 3.04x | 1.89x | 1.23x | 1.54x | 1.42x | 2.05x | 1.25x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 214M | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EMN Key Ratios
Eastman Chemical Company (EMN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 28.92% | 18.87% | 12.75% | 7.87% | 14.41% | 14.39% | 16.61% | 15.9% | 7.97% | 6.69% |
Return on Invested Capital (ROIC) | 9.98% | 9.31% | 8.47% | 7.41% | 10.01% | 7.84% | 8.21% | 10.12% | 6.71% | 6.55% |
Gross Margin | 26.1% | 24% | 24.31% | 23.69% | 24.02% | 19.52% | 22.42% | 24.41% | 21.07% | 19.77% |
Net Margin | 15.49% | 10.67% | 8.21% | 5.65% | 8.18% | 7.53% | 9.72% | 9.65% | 5.42% | 4.62% |
Debt / Equity | 1.17x | 1.05x | 0.96x | 0.92x | 0.95x | 0.98x | 0.93x | 0.90x | 0.84x | 0.00x |
Interest Coverage | 6.26x | 6.48x | 5.05x | 3.59x | 6.64x | 6.16x | 5.82x | 5.99x | 3.73x | 2.22x |
FCF Conversion | 1.12x | 1.43x | 1.98x | 3.04x | 1.89x | 1.23x | 1.54x | 1.42x | 2.05x | 1.25x |
Revenue Growth | 6.36% | 6.39% | -8.64% | -8.47% | 23.85% | 0.5% | -12.69% | 2% | -6.71% | -7.72% |
Related:EMN Dividend History·EMN Revenue History·EMN Price History·EMN P/E History·EMN Financial Ratios·EMN Institutional Holders
EMN SEC Filings & Documents
Eastman Chemical Company (EMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
EMN Frequently Asked Questions
Eastman Chemical Company (EMN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Eastman Chemical Company (EMN) reported $8.64B in revenue for fiscal year 2025. This represents a 81% increase from $4.78B in 1996.
Eastman Chemical Company (EMN) saw revenue decline by 6.7% over the past year.
Yes, Eastman Chemical Company (EMN) is profitable, generating $399.0M in net income for fiscal year 2025 (5.4% net margin).
Dividend & Returns
Yes, Eastman Chemical Company (EMN) pays a dividend with a yield of 4.55%. This makes it attractive for income-focused investors.
Eastman Chemical Company (EMN) has a return on equity (ROE) of 8.0%. This is below average, suggesting room for improvement.
Eastman Chemical Company (EMN) generated $498.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.